Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Neuraxis (NRXS) over the last 4 years, with Q2 2025 value amounting to $7288.0.

  • Neuraxis' Capital Expenditures fell 1609.49% to $7288.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $25288.0, marking a year-over-year decrease of 4228.59%. This contributed to the annual value of $27776.0 for FY2024, which is 976.25% down from last year.
  • Per Neuraxis' latest filing, its Capital Expenditures stood at $7288.0 for Q2 2025, which was down 1609.49% from $18000.0 recorded in Q1 2025.
  • In the past 5 years, Neuraxis' Capital Expenditures registered a high of $18000.0 during Q1 2025, and its lowest value of -$10000.0 during Q4 2022.
  • Moreover, its 4-year median value for Capital Expenditures was $7448.0 (2023), whereas its average is $7384.5.
  • In the last 5 years, Neuraxis' Capital Expenditures skyrocketed by 26040.0% in 2023 and then crashed by 1609.49% in 2025.
  • Neuraxis' Capital Expenditures (Quarter) stood at -$10000.0 in 2022, then surged by 260.4% to $16040.0 in 2023, then tumbled by 72.77% to $4368.0 in 2024, then surged by 66.85% to $7288.0 in 2025.
  • Its last three reported values are $7288.0 in Q2 2025, $18000.0 for Q1 2025, and $4368.0 during Q3 2024.